共 86 条
- [1] Chen YP(2019)Nasopharyngeal carcinoma Lancet 394 64-80
- [2] Chan ATC(2019)Current treatment landscape of nasopharyngeal carcinoma and potential trials evaluating the value of immunotherapy J Natl Cancer Inst 111 655-663
- [3] Le QT(2015)Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicities Oral Oncol 51 190-194
- [4] Blanchard P(2019)Management of locally recurrent nasopharyngeal carcinoma Cancer Treat Rev 79 101890-1308
- [5] Sun Y(2018)Clinical utility of simultaneous whole-body 18 F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma Eur J Nucl Med Mol Imaging 45 1297-95
- [6] Ma J(2019)Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: a pilot study Oral Oncol 93 91-36
- [7] Le QT(2018)International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma Radiother Oncol 126 25-1230
- [8] Colevas AD(2019)Prognostic value and staging classification of lymph nodal necrosis in nasopharyngeal carcinoma after intensity-modulated radiotherapy Cancer Res Treat 51 1222-309
- [9] O'Sullivan B(2020)Technical improvements in head and neck MR imaging: at the cutting edge Neuroimaging Clin N Am 30 295-187
- [10] Lee AWM(2020)Preliminary clinical results for PET/MR compared with PET/CT in patients with nasopharyngeal carcinoma Oncol Rep 43 177-1591